Integral Health Asset Management’s CVS Health CVS Stock Holding History

Integral Health Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114M	Buy	1,100,000 +950,000	+633%	+$84.8M	4.49%	4
2026 Q1	$10.8M	Sell	150,000 -350,000	-70%	-$27M	0.52%	55
2025 Q4	$39.7M	Buy	500,000 +300,000	+150%	+$23.7M	1.97%	11
2025 Q3	$15.1M	Sell	200,000 -50,000	-20%	-$3.43M	1.02%	30
2025 Q2	$17.2M	Buy	250,000 +50,000	+25%	+$3.28M	1.58%	23
2025 Q1	$13.6M	Sell	200,000 -300,000	-60%	-$18M	1.44%	18
2024 Q4	$22.4M	Buy	+500,000	New	+$28.1M	1.91%	13
2022 Q4	–	Sell	-130,000	Closed	-$12.4M	–	72
2022 Q3	$12.4M	Sell	130,000 -10,898	-8%	-$1.08M	2.41%	16
2022 Q2	$13.1M	Buy	140,898 +50,898	+57%	+$4.97M	2.69%	13
2022 Q1	$9.11M	Buy	90,000 +5,000	+6%	+$525K	2.37%	16
2021 Q4	$8.77M	Sell	85,000 -65,000	-43%	-$6.01M	2.43%	12
2021 Q3	$12.7M	Buy	+150,000	New	+$12.6M	3.66%	4
2021 Q2	–	Sell	-20,000	Closed	-$1.5M	–	78
2021 Q1	$1.5M	Sell	20,000 -80,000	-80%	-$5.83M	0.43%	57
2020 Q4	$6.83M	Buy	+100,000	New	+$6.5M	2.03%	22
2020 Q1	–	Sell	-100,000	Closed	-$7.43M	–	60
2019 Q4	$7.43M	Buy	+100,000	New	+$7.02M	2.89%	17

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Integral Health Asset Management's CVS Position: Q2 2026 in Review

Integral Health Asset Management increased its CVS Health (CVS) stake by 633% in Q2 2026, buying an estimated $84.8M and bringing the position to 1,100,000 shares worth $114M. The position accounts for 4.49% of the portfolio, ranked #4.

Integral Health Asset Management first reported a position in CVS in Q4 2019 and has held it in 15 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Integral Health Asset Management held 1,100,000 shares of CVS Health worth $114M as of Q2 2026.
Integral Health Asset Management bought 950,000 CVS Health shares in Q2 2026, an estimated $84.8M.
CVS Health made up 4.49% of Integral Health Asset Management's portfolio in Q2 2026, its #4 holding.
Integral Health Asset Management first reported a position in CVS Health in Q4 2019 and has held it in 15 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.